This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilson, M. L.
Right arrow Articles by Reller, L. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilson, M. L.
Right arrow Articles by Reller, L. B.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 1999, p. 1709-1713, Vol. 37, No. 6
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Controlled Clinical Comparison of bioMérieux VITAL and BACTEC NR-660 Blood Culture Systems for Detection of Bacteremia and Fungemia in Adults

Michael L. Wilson,1,2,* Stanley Mirrett,3 L. Clifford McDonald,3 Melvin P. Weinstein,4,5,6 Jose Fune,5 and L. Barth Reller3,7,8

Department of Pathology and Laboratory Services, Denver Health, Denver, Colorado 802041; Department of Pathology, University of Colorado School of Medicine, Denver, Colorado 802622; Clinical Microbiology Laboratory, Duke University Medical Center,3 and Departments of Pathology7 and Medicine,8 Duke University School of Medicine, Durham, North Carolina 27710; and Microbiology Laboratory, Robert Wood Johnson University Hospital4 and Departments of Medicine5 and Pathology,6 University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901

Received 4 November 1998/Returned for modification 17 December 1998/Accepted 23 February 1999

A total of 9,446 blood cultures were collected from adult patients at three university-affiliated hospitals. Of these, 8,943 cultures were received with both aerobic bottles filled adequately; 885 yielded 1,016 microorganisms, including 622 isolates (61%) that were the cause of sepsis, 337 isolates (33%) that were contaminants, and 57 isolates (6%) that were indeterminate as the cause of sepsis. With the exception of Staphylococcus aureus, which was recovered more often from VITAL aerobic bottles, more pathogenic microorganisms were recovered from BACTEC NR6 (aerobic) bottles than from VITAL aerobic bottles. Growth of pathogenic microorganisms was detected earlier in VITAL aerobic bottles. A total of 8,647 blood cultures were received with both anaerobic bottles filled adequately; 655 yielded 740 microorganisms, including 486 isolates (66%) that were the cause of sepsis, 215 isolates (29%) that were contaminants, and 39 isolates (6%) that were indeterminate as the cause of sepsis. More pathogenic microorganisms were recovered from VITAL anaerobic bottles than from BACTEC NR7 (anaerobic) bottles. Growth of pathogenic microorganisms was detected earlier in VITAL anaerobic bottles. In 8,500 sets all four bottles were received adequately filled. When paired aerobic and anaerobic bottle sets (systems) were compared, more pathogenic microorganisms (again with the exception of S. aureus) were recovered from the BACTEC system. For the 304 septic episodes (253 unimicrobial and 51 polymicrobial), significantly more were detected by the BACTEC system. We conclude that VITAL requires modification to improve recovery of pathogenic microorganisms to make it competitive with other commercially available blood culture systems.


* Corresponding author. Mailing address: Medical Laboratories #0224, Denver Health Medical Center, 777 Bannock St., Denver, CO 80204-4507. Phone: (303) 436-6434. Fax: (303) 436-6420. E-mail: mwilson{at}dhha.org.


Journal of Clinical Microbiology, June 1999, p. 1709-1713, Vol. 37, No. 6
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Golan, Y., Wolf, M. P., Pauker, S. G., Wong, J. B., Hadley, S. (2005). Empirical Anti-Candida Therapy among Selected Patients in the Intensive Care Unit: A Cost-Effectiveness Analysis. ANN INTERN MED 143: 857-869 [Abstract] [Full Text]  
  • Carrigan, S. D., Scott, G., Tabrizian, M. (2004). Toward Resolving the Challenges of Sepsis Diagnosis. Clin. Chem. 50: 1301-1314 [Abstract] [Full Text]